Abstract
The discovery of reliable biomarkers is essential for early diagnosis, personalized treatment, and effective disease management. Biotechnology plays a central role in identifying and validating disease biomarkers, particularly in complex diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders. Advances in genomics, proteomics, and metabolomics, coupled with innovations in bioinformatics and molecular biology, have transformed the landscape of biomarker discovery. This article explores the role of biotechnology in disease biomarker discovery, highlighting the technologies and methodologies driving progress, as well as the challenges and future prospects in the field.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Dr. Alice Bennett, Dr. David Roberts (Author)